AngioDynamics publishes revised annual report filing (Form 10-K/A)
ANGO•AngioDynamics amended its fiscal 2026 annual report to add previously omitted Part III disclosures, restating Items 10 through 14 without revising financial statements or other sections.
1. Amended annual report
AngioDynamics published an amended fiscal 2026 annual report to add previously omitted Part III disclosures and restate Items 10 through 14. The amendment does not revise the financial statements or update other sections of the original report.
